Dyslipidemia in AIDS patients on highly active antiretroviral therapy

Dyslipidemia in AIDS patients on highly active antiretroviral therapy

Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, however it has been associated with metabolic abnormalities. This study estimated the prevalence of lipid abnormalities and related factors among patients on HAART. A cross-sectional study was conducted on adu...

Full description

Bibliographic Details
Main Authors:	Max Weyler Nery, MD, MSc, Celina Maria Turchi Martelli, MD, PhD, Marília Dalva Turchi, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2011-03-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867011701611

Similar Items

Dyslipidemia in AIDS patients on highly active antiretroviral therapy
by: Max Weyler Nery, et al.

Mother-to-child transmission of HIV: risk factors and missed opportunities for prevention among pregnant women attending health services in Goiânia, Goiás State, Brazil Transmissão vertical do HIV: fatores associados e perdas de oportunidades de intervenção em gestantes atendidas em Goiânia, Goiás, Brasil
by: Marília Dalva Turchi, et al.
Published: (2007-01-01)

Zika virus infection and microcephaly: spatial analysis and socio-environmental determinants in a region of high Aedes aegypti infestation in the Central-West Region of Brazil
by: Patrícia Silva Nunes, et al.
Published: (2021-10-01)

Prevalence of hepatitis B and C infection and associated factors in people living with HIV in Midwestern Brazil
by: Natália Alberto Alves Brandão, et al.
Published: (2015-07-01)

Skin Diseases in the Era of Highly Active Antiretroviral Therapy: A Retrospective Study of 534 Patients
by: Jennifer Tan MD, MSc, et al.
Published: (2018-01-01)

Clinical practice in COVID-19: The most frequently asked questions to infectious diseases specialists
by: Moara Alves Santa Bárbara Borges, MD, MSc, et al.
Published: (2021-11-01)

Qualidade de vida: compromisso histórico da epidemiologia
by: Martelli Celina Maria Turchi
Published: (1995-01-01)

Qualidade de vida: compromisso histórico da epidemiologia
by: Celina Maria Turchi Martelli
Published: (1995-03-01)

Qualidade de vida: compromisso histórico da epidemiologia
by: Celina Maria Turchi Martelli

Cardiovascular Risk Assessment: A Comparison of the Framingham, PROCAM, and DAD Equations in HIV-Infected Persons
by: Max Weyler Nery, et al.
Published: (2013-01-01)

Trends & predictors of non-AIDS comorbidities among people living with HIV and receiving antiretroviral therapy in Lebanon
by: Farouk F. Abou Hassan, MS, et al.
Published: (2022-04-01)

Late Onset of Antiretroviral Therapy in Adults Living with HIV in an Urban Area in Brazil: Prevalence and Risk Factors
by: Priscila Ribeiro Guimarães Pacheco, et al.
Published: (2019-01-01)

Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs
by: Mariusa Gomes Borges Primo, et al.
Published: (2012-11-01)

Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs
by: Mariusa Gomes Borges Primo, et al.

Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs
by: Mariusa Gomes Borges Primo, et al.
Published: (2012-12-01)

Macular arteritis in an HIV-infected patient improving with adherence to antiretroviral therapy
by: Elisabeth Boddé, MD, et al.
Published: (2020-08-01)

Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor
by: Gustavo Romero‐Velez, MD, et al.
Published: (2014-04-01)

Analysis of the Impact of Antiretroviral Drug Changes on Survival of Patients with Advanced-Stage AIDS with Multidrug-Resistant HIV Infection
by: Rui Ma MSc, et al.
Published: (2019-07-01)

Long-Term Trends of Coagulation Parameters in People Living With HIV Treated With Combined Antiretroviral Therapy
by: Soerajja Bhoelan MD, et al.
Published: (2023-03-01)

Predictors of Virologic Failure in HIV/AIDS Patients Treated with Highly Active Antiretroviral Therapy in Brasilia, Brazil during 2002–2008
by: Edson José Monteiro Bello M.Sc., et al.
Published: (2011-01-01)

Development of dyslipidemias in a cohort of Mexican adult patients with HIV/AIDS under highly active antiretroviral therapy
by: Guadalupe López-Rodríguez, et al.
Published: (2024-01-01)

Systemic Dyslipidemia in Age-related Macular Degeneration
by: Brandon Li, et al.
Published: (2024-01-01)

HIV-Positive Patients’ Perceptions of Antiretroviral Therapy Adherence in Relation to Subjective Time: Imprinting, Domino Effects, and Future Shadowing
by: David Lessard PhD, et al.
Published: (2018-02-01)

Commentary: Postcoronary artery bypass grafting treatment of dyslipidemia: Better hit those targets!Central Message
by: Walid Ben Ali, MD, PhD, et al.
Published: (2022-06-01)

Dyslipidemia among HIV/AIDS patients receiving antiretroviral therapy: A prospective observational study
by: A. Biswas, et al.
Published: (2014-04-01)

Sociodemographic and Clinical Predictors of Weight Gain During the First Year of Antiretroviral Therapy among Adults Living With HIV in Urban Tanzania
by: Pilly Chillo MD, PhD, et al.
Published: (2024-10-01)

“Testing, Testing”: Multiple HIV-Positive Tests among Patients Initiating Antiretroviral Therapy in Ethiopia
by: Sarah Kulkarni MPH, et al.
Published: (2017-11-01)

Predictors of Clinical Progression in HIV-1-Infected Adults Initiating Combination Antiretroviral Therapy with Advanced Disease in the Asia-Pacific Region
by: H. Byakwaga MBChB, PhD, et al.
Published: (2013-07-01)

Sexual Dysfunctions Among People Living With HIV With Long-Term Treatment With Antiretroviral Therapy
by: Marco De Tubino Scanavino, PhD, et al.
Published: (2022-10-01)

An Evaluation of Hepatitis B Virus Diagnostic Methods and Responses to Antiretroviral Therapy among HIV-Infected Women in Thailand
by: Philip James Peters MD, et al.
Published: (2013-09-01)

Self-Report Measures in the Assessment of Antiretroviral Medication Adherence
by: Lassane Kabore PharmD, MSc, MSPH, et al.
Published: (2015-03-01)

IMMUNOGENICITY OF LOW-DOSE INTRAMUSCULAR AND INTRADERMAL VACCINATION WITH RECOMBINANT HEPATITIS B VACCINE
by: Marília Dalva TURCHI, et al.
Published: (1997-01-01)

A Minority of Patients Newly Diagnosed with AIDS Are Started on Antiretroviral Therapy at the Time of Diagnosis in a Large Public Hospital in the Southeastern United States
by: Neela D. Goswami MD, MPH, et al.
Published: (2017-03-01)

Association of HIV/AIDS Clinician Warm Line Utilization with Diagnosis and Management of Antiretroviral Treatment Failure in Mozambique: A Retrospective Analysis of Program Data
by: Maria Ruano Camps MD, et al.
Published: (2017-07-01)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
by: Suzy Maria MD, et al.
Published: (2020-01-01)

Lipid-Lowering and Antioxidant Functions of Bottle Gourd () Extract in Human Dyslipidemia
by: Charu Katare PhD, et al.
Published: (2014-04-01)

Dyslipidemia impairs collateral artery formation after hindlimb ischemia: Adding insult to injury
by: Ali H. Hakim, MD, et al.
Published: (2024-01-01)

Advanced HIV Disease at Antiretroviral Therapy Initiation and Treatment Outcomes Among Children and Adolescents Compared to Adults Living With HIV in Kinshasa, Democratic Republic of the Congo
by: Otto Nzapfurundi Chabikuli MD, MFamMed, MSc, et al.
Published: (2023-12-01)

Hepatitis C virus prevalence among an immigrant community to the Southern Amazon, Brazil
by: Francisco José Dutra Souto, et al.
Published: (1999-11-01)

Welfare Homes for Patients Living with HIV/AIDS in Andalusia
by: Radka Ivanova MD, PhD, et al.
Published: (2014-09-01)